Suchergebnisse - "Dawoud, Dalia"

PubPharm (146)

31

Diagnostics and Treatments of COVID-19 : A Living Systematic Review of Economic Evaluations

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2022

von Elvidge, J. | Summerfield, A. | Nicholls, D. | +1

32

Correction to: New onset of axial spondyloarthropathy in patients treated with isotretinoin for acne vulgaris: incidence, follow-up, and MRI findings

enthalten in: Clinical rheumatology | 2022

von Elnady, B. | Elkhouly, T. | Dawoud, N. | +4

33

Correction to: New onset of axial spondyloarthropathy in patients treated with isotretinoin for acne vulgaris: incidence, follow-up, and MRI findings

enthalten in: Clinical rheumatology | 2022

von Elnady, B. | Elkhouly, T. | Dawoud, N. | +4

34

Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS

enthalten in: ResearchSquare.com | 2022

von Prieto-Alhambra, D. | Kostka, K. | Duarte-Salles, T. | +72

35

Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and Challenges

enthalten in: PharmacoEconomics | 2022

von Gomes, M. | Latimer, N. | Soares, M. | +6

36

Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and Challenges

enthalten in: PharmacoEconomics | 2022

von Gomes, M. | Latimer, N. | Soares, M. | +6

37

Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and Challenges

enthalten in: PharmacoEconomics | 2022

von Gomes, M. | Latimer, N. | Soares, M. | +6

38

Capturing what matters: updating NICE methods guidance on measuring and valuing health

enthalten in: Quality of life research | 2022

von Dawoud, D. | Lamb, A. | Moore, A. | +6

39

Current Approaches to Vaccine Safety Using Observational Data : A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design

enthalten in: Frontiers in pharmacology | 2022

von Lai, L. | Arshad, F. | Areia, C. | +12

40

Outcome-based reimbursement in Central-Eastern Europe and Middle-East

enthalten in: Frontiers in medicine | 2022

von Ádám, I. | Callenbach, M. | Németh, B. | +17